UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

~~PURSUANT~~Pursuant TOto ~~SECTION~~Section 13 ORor 15(d)

OFof ~~THE~~the ~~SECURITIES~~Securities ~~EXCHANGE~~Exchange ~~ACT~~Act OFof 1934

Date of report (Date of earliest event reported): ~~August~~September 63, 2025

Oscar Health, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware

001-40154

46-1315570

~~001-40154~~

~~46-1315570~~

(State or Other Jurisdictionof Incorporation)

(CommissionFile Number)

(IRS EmployerIdentification No.)

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

75 Varick Street, 5th Floor New York, New York 10013 (Address of Principal Executive Offices) (Zip Code)

New York, New York 10013

(Address of Principal Executive Offices) (Zip Code)

(646) 403-3677

(Registrant’s telephone number, including area code)

Not ~~applicable~~ Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

~~TradingSymbols~~

~~Name of each exchangeon which registered~~

Class A Common Stock, $0.00001 par value per share

OSCR

New York Stock Exchange

~~OSCR~~

~~New York Stock Exchange~~

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2 7.0201. ~~Results~~Regulation ofFD ~~Operations and Financial Condition~~Disclosure.

~~On August 6, 2025,~~ Oscar Health, Inc. (the “Company”) ~~announced~~will participate in the ~~Company’s~~2025 ~~financial~~Wells ~~results~~Fargo ~~for~~Healthcare Conference (the ~~quarter~~“Conference”) ~~ended~~on ~~June 30~~September 3, 2025. AAt ~~copy~~the ofConference, the ~~press~~Company ~~release~~will ~~issued~~reaffirm inthe ~~connection~~updated ~~with~~full ~~the~~year ~~announcement~~2025 isguidance ~~attached~~that ~~and~~it ~~furnished~~provided asin ~~Exhibit 99.1~~its topreliminary ~~this~~financial ~~Current~~results ~~Report~~press onrelease ~~Form~~for ~~8-K~~the ~~and~~second ~~incorporated~~quarter ~~herein~~of by2025, ~~reference~~dated July 22, 2025.

~~The~~This information ~~in Item 2.02 and Exhibit 99.1 of this Current Report on Form 8-K~~ shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or ~~otherwise subject to the liabilities of that section, nor shall such information and exhibits be deemed~~ incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in any such a filing.

~~Item~~Cautionary ~~9.01.~~Note ~~Financial~~Regarding Forward-Looking Statements ~~and Exhibits.~~

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward- looking statements. These statements include, but are not limited to, statements about our expected financial performance and upcoming events and presentations. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, and uncertainties that are difficult to predict and generally beyond our control. Although management believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, there are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission (d“SEC”), ~~Exhibits~~our Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, and our other filings with the SEC. You are cautioned not to place undue reliance on any forward-looking statements made herein. Any forward-looking statement speaks only as of the date as of which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward- looking statement, whether as a result of new information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us to predict which will arise.

Exhibit No.						Description
99.1						Press Release, dated August 6, 2025
104						Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Oscar Health, Inc. By: /s/ R. Scott Blackley Name: R. Scott Blackley Title: Chief Financial Officer

Date: August 6, 2025

Oscar Health, Inc.

Date: September 3, 2025

/s/ R. Scott Blackley

R. Scott Blackley

Chief Financial Officer

Filing Compare · Oscar Health, Inc.